|
|
|
|
||
|
||
|
Vol. 8, Nos. 1-50, pp. 1-1650 Jan. 1 -- Dec. 31, 2010 # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Ocular Research of Boston Inc. v. Allergan Inc. (E.D. Tex.), 747
Omeprazole Patent Litig., In re (S.D.N.Y.), 811 Omnicare Inc.; Laborers Dist. Council Constr. Indus. Pension Fund v. (U.S., dism), 1433 Omnicare Inc.; U.S. ex rel. Kammerer v. (N.D. Ill.), 1213 Omni Med. Group; Echols v. (N.D. Okla.), 1510 Onujiogu; U.S. v. (D. Mass.), 1187 Organon Inc.; U.S. ex rel. Feldstein v. (3d Cir.), 182 Orgenus Pharma Inc.; Wyeth v. (D.N.J.), 1398 Orion Corp. v. Sun Pharma Global Inc. (D.N.J.), 813 Orion Corp. v. Sun Pharm. Indus. Ltd. (D.N.J.), 813 Ortho Biotech Prods. LP v. U.S. ex rel. Duxbury (U.S., rev sought), 37; 231; (rev den), 810 Ortho Evra Prods. Liab. Litig., In re (N.D. Ohio), 160 Ortho-McNeil-Janssen Pharms. Inc. v. Amneal Pharms. LLC (D.N.J.), 747 Ortho-McNeil Pharm. Inc. v. Lupin Pharms. Inc. (Fed. Cir.), 617; 976 Ortho-McNeil Pharm. Inc.; U.S. ex rel. Maher v. (D. Mass.), 585 Oscient Pharms. Corp., In re (Bankr. D. Mass.), 749; 920 Otsuka Pharm. Co. v. Sandoz Inc. (D.N.J.), 1458 OxyContin II, In re (N.Y. App. Div.), 1278 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |
